Olympus will now look to shake off the controversies its endoscopy business has faced in the last couple of years.

Valens Semiconductor (NYSE: VLN) announced today that the first endoscopes powered by its VA7000 chipset will be launched by three OEMs, signaling strong momentum for Valens' entry into the medical ...

The Europe integrated LED light source endoscope market is set to surge to $1.10 billion by 2035, rising from $241.6 million ...

Hong Kong’s Medical Council is under mounting pressure to account for its disciplinary procedures after concerns were raised ...

Valens ( ($VLN) ) just unveiled an update. On November 10, 2025, Valens Semiconductor announced the launch of the first endoscopes using its ...

Aqua Medical has received investigational device exemption (IDE) from the FDA for its ablation device aimed at treating ...

The latest update is out from Jinhai International Group Holdings Limited ( ($HK:2225) ). Jinhai Medical Technology Limited announced a strategic ...

South Korea-based MOPIC has introduced an autostereoscopic 3D display aimed at endoscopic and microscope imaging applications ...

JLL will be merging Parks with portfolio company Vascular Technology Incorporated, a Nashua, New Hampshire-based medical ...

The IDE approval marks a pivotal milestone for Aqua Medical, allowing the company to begin enrolling patients in the U.S. RESTORE-1 pilot trial and study PIMA's potential to deliver durable metabolic ...

The workforce reduction is part of a restructuring designed to improve accountability and accelerate growth and innovation.